The federal Food and Drug Administration (FDA) has withdrawn its emergency use authorization (EUA) of two anti-malaria drugs to treat COVID-19 patients, the agency said. The drugs affected, chloroquine phosphate and hydroxychloroquine sulfate, are normally used to combat malaria. But under the EUA, the FDA allowed them to be used to treat some patients with… Continue reading FDA Withdraws Emergency Approval of Anti-Malaria Drugs to Treat COVID-19